DelMar Pharma, Del Mar Pharmaceuticals Ltd. deal

Cancer company Del Mar Pharmaceuticals Ltd. reverse-merged with public shell company DelMar Pharmaceuticals Inc. (formerly Berry Only Inc.). DelMar issued about 13.1 million shares to former Del Mar shareholders, or about an 80.1% stake. The combined company retained the DelMar Pharmaceuticals Inc. name and changed its ticker to "DMPI" from "BRRY." ...